CSL Limited CSJA.F Stock
CSL Limited Price Chart
CSL Limited CSJA.F Financial and Trading Overview
| CSL Limited stock price | 85 EUR |
| Previous Close | 87.5 EUR |
| Open | 86.5 EUR |
| Bid | 87 EUR x 30000 |
| Ask | 89 EUR x 30000 |
| Day's Range | 86.5 - 86.5 EUR |
| 52 Week Range | 83.5 - 102 EUR |
| Volume | 60 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 84.49B EUR |
| Beta (5Y Monthly) | 0.217241 |
| PE Ratio (TTM) | 46.505375 |
| EPS (TTM) | 2.37 EUR |
| Forward Dividend & Yield | 1.1 (1.14%) |
| Ex-Dividend Date | March 8, 2023 |
| 1y Target Est | N/A |
CSJA.F Valuation Measures
| Enterprise Value | 98.65B EUR |
| Trailing P/E | 46.505375 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.2185693 |
| Price/Book (mrq) | 5.321767 |
| Enterprise Value/Revenue | 8.429 |
| Enterprise Value/EBITDA | 28.628 |
Trading Information
CSL Limited Stock Price History
| Beta (5Y Monthly) | 0.217241 |
| 52-Week Change | 4.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 102 EUR |
| 52 Week Low | 83.5 EUR |
| 50-Day Moving Average | 91.29 EUR |
| 200-Day Moving Average | 92.58 EUR |
CSJA.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 964.74M |
| Float | 962.25M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.073% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 2.57% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5139 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 18.09% |
| Operating Margin (ttm) | 25.38% |
| Gross Margin | 52.52% |
| EBITDA Margin | 29.44% |
Management Effectiveness
| Return on Assets (ttm) | 6.30% |
| Return on Equity (ttm) | 13.37% |
Income Statement
| Revenue (ttm) | 11.7B EUR |
| Revenue Per Share (ttm) | 12.16 EUR |
| Quarterly Revenue Growth (yoy) | 18.89% |
| Gross Profit (ttm) | 5.73B EUR |
| EBITDA | 3.45B EUR |
| Net Income Avi to Common (ttm) | 2.12B EUR |
| Diluted EPS (ttm) | 1.86 |
| Quarterly Earnings Growth (yoy) | -7.79% |
Balance Sheet
| Total Cash (mrq) | 1.51B EUR |
| Total Cash Per Share (mrq) | 1.56 EUR |
| Total Debt (mrq) | 12.12B EUR |
| Total Debt/Equity (mrq) | 67.77 EUR |
| Current Ratio (mrq) | 2.218 |
| Book Value Per Share (mrq) | 16.254 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18B EUR |
| Levered Free Cash Flow (ttm) | -113812496 EUR |
Profile of CSL Limited
| Country | Germany |
| State | VIC |
| City | Parkville |
| Address | 45 Poplar Road |
| ZIP | 3052 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30000 |
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Q&A For CSL Limited Stock
What is a current CSJA.F stock price?
CSL Limited CSJA.F stock price today per share is 85 EUR.
How to purchase CSL Limited stock?
You can buy CSJA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL Limited?
The stock symbol or ticker of CSL Limited is CSJA.F.
Which industry does the CSL Limited company belong to?
The CSL Limited industry is Biotechnology.
How many shares does CSL Limited have in circulation?
The max supply of CSL Limited shares is 976.47M.
What is CSL Limited Price to Earnings Ratio (PE Ratio)?
CSL Limited PE Ratio is 35.86498000 now.
What was CSL Limited earnings per share over the trailing 12 months (TTM)?
CSL Limited EPS is 2.37 EUR over the trailing 12 months.
Which sector does the CSL Limited company belong to?
The CSL Limited sector is Healthcare.